Simvastatina para la prevención de exacerbaciones en EPOC moderada a grave
Simvastatin for the prevention of exacerbations of moderate-to-severe COPD
Contenido principal del artículo
Detalles del artículo
Referencias (VER)
Dobler CC, Wong KK, Marks GB. Associations between statins and COPD: a systematic review. BMC Pulm Med. 2009;9:32.
Janda S, Park K, FitzGerald JM, Etminan M, Swiston J. Statins in COPD: a systematic review. Chest. 2009;136:734-43.
Horita N, Miyazawa N, Kojima R, Inoue M, Ishigatsubo Y, Ueda A, Kaneko T. Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies. Respir Res. 2014;15:80.
Young RP, Hopkins RJ, Agusti A. Statins as adjunct therapy in COPD: how do we cope after STATCOPE? Thorax. 2014;69: 891-4.
Mancini GB, Road J. Are Statins out in the COLD? The STATCOPE Trial. Can J Cardiol. 2015;31:970-3.